Aileen Pangan

Biography
Aileen Pangan is a rheumatologist with 22 years of industry experience. She joined Merck in Feb 2022 to head Immunology Clinical Research, setting and driving late-stage pipeline strategy. Prior to Merck, she was Executive Medical Director at Abbvie where she led a clinical team in the design and execution of phase 2-3 programs in rheumatology, gastroenterology and dermatology, and global regulatory filings for multiple indications for RINVOQ. She previously led phase 3 programs in rheumatology and ophthalmology for HUMIRA and spent 5 years in Global Medical Affairs as the Rheumatology team lead supporting HUMIRA. Prior to industry, Aileen was Assistant Professor of Medicine at Loyola University Medical Center in Chicago. She previously served as Corporate Representative to the Board of Directors of the Rheumatology Research Foundation, and as a member of the Development Advisory Council and National Advisory Council, as well as the Committee on Research of the American College of Rheumatology.